Intratumoral CD8+ Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumoral CD8+ Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 4, Pages e95475
Publisher
Public Library of Science (PLoS)
Online
2014-04-18
DOI
10.1371/journal.pone.0095475
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin C as a Compatible Prognostic Marker in Human Solid Tumors
- (2012) M. Schmidt et al. CLINICAL CANCER RESEARCH
- Immunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer
- (2012) Zonglin Chen et al. PLoS One
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity
- (2011) Ensel Oh et al. BREAST CANCER RESEARCH AND TREATMENT
- CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
- (2011) Fangfang Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model
- (2011) Tamar Tadmor et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors
- (2011) Junzo Hamanishi et al. CLINICAL IMMUNOLOGY
- In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype
- (2011) David Anz et al. HISTOPATHOLOGY
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
- (2010) Sahar M. A. Mahmoud et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers
- (2010) Giampaolo Bianchini et al. JOURNAL OF CLINICAL ONCOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Differences in Tumor Regulatory T-Cell Localization and Activation Status Impact Patient Outcome
- (2009) C. Menetrier-Caux et al. CANCER RESEARCH
- Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
- (2009) M. Gobert et al. CANCER RESEARCH
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer
- (2008) Alberto Calabrò et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now